fda glp-1 compounding enforcement october 2025 Ozempic's patent problem: how Novo Nordisk lost control of a blockbuster drug. 💉 Demand for weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite From Shortage Heroes to Compliance

Record the injection site and date to help with site rotation

change the injection site with each dose

A new study published in Cell Metabolism found that semaglutide (a GLP-1) may help alleviate osteoarthritis related inflammation and tissue damage including cartilage destruction, osteophyte formation and pain sensitivity, independent of weight loss

There's a Kindle version of that one as well for really inexpensive pricing

The impact of UA levels in patients with PD still requires validation through further prospective studies

Clinical trials have demonstrated significant reductions in hemoglobin A1c levels (approximately 1.52.0% from baseline) and substantial weight loss (averaging 1015% of body weight with higher doses)